A new publication authored by RID Program team members Dr. Jeffrey Wong, Melissa Watt, Dr. Chelsea Elwood, and Dr. Julie van Schalkwyk has been published in Acta Obstetricia et Gynecologica Scandinavica! This publication, entitled “Antepartum versus postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study” describes findings from data collected from pregnant patients of penicillin allergy delabelling clinics at BC Women’s Hospital in Vancouver, BC and another in Winnipeg, MB. It describes the differences in efficacy, adverse events and patient satisfaction between these two clinics, as the site in BC employed amoxicillin oral challenge (either automatically or after a negative penicillin skin test) to patients during the antepartum period, whereas the Winnipeg site employed only penicillin skin testing during the antepartum period and oral amoxicillin challenge during a follow-up visit in the postpartum period. Key findings from the publication included 98% of patients who recieved an oral amoxicillin challenge passing the challenge (no allergic reaction), 70% of patients from the Winnipeg site being lost to follow-up prior to the postpartum oral amoxicillin challenge being completed, and much higher percentage of patients delabelled from the allergy (97%) at the Vancouver site than at the Winnipeg site (38%). For more information on these and other findings, please click here to access the publication!